The Interleukin 6 pipeline drugs market research report outlays comprehensive information on the Interleukin 6 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Interleukin 6 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Immunology, Oncology, Infectious Disease, and Ophthalmology which include the indications Rheumatoid Arthritis, Inflammation, Unspecified Cancer, Lung Cancer, Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome, Diabetic Macular Edema, and Uveitis. It also reviews key players involved in Interleukin 6 targeted therapeutics development with respective active and dormant or discontinued products.
The Interleukin 6 pipeline targets constitutes close to 26 molecules. Out of which, approximately 23 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical, and Discovery stages are 6, 4, 1, 5, and 6 respectively. Similarly, the universities portfolio in Phase 0, and Preclinical comprises 1, and 2 molecule.
Interleukin 6 overview
IL6 is a cytokine with biological functions in immunity, tissue regeneration, and metabolism. It binds to IL6R, then the complex associates to the signaling subunit IL6ST/gp130 to trigger the intracellular IL6-signaling pathway. The interaction with the membrane-bound IL6R and IL6ST stimulates classic signaling, whereas the binding of IL6 and soluble IL6R to IL6ST stimulates trans-signaling. Alternatively, cluster signaling occurs when membrane-bound IL6:IL6R complexes on transmitter cells activate IL6ST receptors on neighboring receiver cells.
For a complete picture of Interleukin 6’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.